News Scan for Nov 06, 2020

News brief

UK study finds CRP tests tied to lower antibiotic prescribing for cough

The use of point-of-care C-reactive protein (CRP) tests in primary care practices reduced the odds of prescribing antibiotics for cough by 21%, a non-significant but clinically relevant reduction, researchers reported yesterday in Eurosurveillance.

Using a pragmatic randomized controlled trial design, researchers from Public Health England allocated the top 19 antibiotic prescribing general practices in Northern England to an intervention group that used CRP point-of-care tests (POCTs) for patients who had symptoms of acute cough, and a control group using standard practice. The eight practices allocated to the intervention arm, with a patient population of 47,000, were given a CRP-POCT machine and 100 CRP tests to use over 6 months.

The primary objective of the study was to determine if the intervention practices had reduced odds of prescribing for lower respiratory tract infection, acute cough, bronchitis, and chest infection. The researchers also evaluated patient satisfaction questionnaires.

The eight practices undertook 268 CRP tests over 6 months. A strong majority of CRP results (78%; 209 of 268) indicated no infection, and management of these patients mainly followed National Institute for Health and Care Excellence (NICE) guidance for self-care and no antibiotics (90%; 188/209). But only 12 (22%) of 54 CRP results that indicated a delayed antibiotic should be considered were managed in line with NICE guidance.

Patients reported that CRP testing was comfortable (88%), convenient (84%), useful (92%), and explained well (85%). Patients believed CRP POCT aided clinical diagnosis, provided quick results, and reduced unnecessary antibiotic use. In consultations for which the diagnosis mentioned cough, intervention practices had an estimated 21% reduction (95% confidence interval: 0.46 to 1.35) in the odds of prescribing an antibiotic compared with the controls.

"In routine general practice, CRP POCT use was variable," the authors wrote. "Non-significant reductions in antibiotic prescribing may reflect small sample size due to non-use of tests. While CRP POCT may be useful, primary care staff need clearer CRP guidance and action planning according to NICE guidance."
Nov 5 Eurosurveill study

 

Vaccine education increases parents' measles concern, survey finds

After 493 Minnesota parents learned that uptake of the measles, mumps, and rubella (MMR) vaccine in their county was below herd immunity levels, 133 (27.0%) had a raised level of concern around measles risk, University of Minnesota researchers reported in Vaccine.

The results come at a time when MMR coverage remains low in some US regions. The study also found that 40.2% of respondents learned that their county's MMR vaccine, while higher than they thought, was below the herd immunity threshold.

The study's data collection took place via onsite electronic surveys at the 2016 Minnesota State Fair, and participants were parents of children from 6 to 18 years old. (Survey advertising did not directly allude to vaccines: "Have you heard about the herd?") Participants were asked about herd immunity, their estimations of their county's MMR vaccination coverage, what herd immunity threshold they thought measles required, and their concern for their children regarding measles. Then, after receiving a short educational intervention about these topics, including their county's coverage, their levels of concern were re-evaluated.

Of the respondents, 334 (67.8%) knew what herd immunity was, with white participants being 3.1 times more likely, metropolitan residents being 2.0 times more likely, and those having at least an associate's degree being 1.7 times more likely. Before the educational intervention, 373 (76%) said they were at least somewhat concerned their child would contract measles without the vaccine. After learning about the MMR vaccine and herd immunity, 354 (72%) said they were at least somewhat concerned, and 304 (62%) said they were at least somewhat concerned about a potential county outbreak.

"Overall, a significant proportion of parents learned that MMR vaccination rates were higher than they expected," the researchers write, "which may have reassured them that measles risk was low in their areas, even though none of the counties had vaccination rates that met the herd immunity threshold."

Of note, the year after the survey was conducted, in 2017, Minnesota officials grappled with a 79-case measles outbreak, the largest in the state since 1990.
Nov 4 Vaccine study

 

China reports another H9N2 avian flu infection

China has reported its seventh H9N2 avian flu case of the year, which involves a 3-year-old girl from Guangdong province who had contact with domestic poultry, the European Centre for Disease Prevention and Control (ECDC) said in its latest weekly communicable disease threat report.

The girl became ill with mild symptoms on Oct 12 and was hospitalized the same day, and she has fully recovered. Investigators found no other related cases among her contacts.

The country reported its last case in August, also involving a young child with mild symptoms from Guangdong province.

Sporadic H9N2 cases have been reported in countries such as China where H9N2 is endemic in poultry. So far children are the most affected group, and the virus in humans has not been linked to sustained transmission.
Nov 6 ECDC weekly communicable disease threat report

 

Eight countries report more polio, including first in Republic of Congo

Eight countries reported new polio cases this week, including the first from the Republic of Congo. Most involved circulating vaccine-derived poliovirus type 2 (cVDPV2), but Pakistan reported one more wild poliovirus type 1 (WPV1) case, according to the latest update from the Global Polio Eradication Initiative (GPEI).

Pakistan's WPV1 case was in Punjab province, raising its total for the year to 80. Elsewhere in the Middle East, Afghanistan reported 20 more cVDPV2 cases in eight different provinces, bringing its total for 2020 to 121.

Six African nations reported cVDPV2 cases. The Republic of Congo case was in Kouilou and is linked to an outbreak in Angola.

Burkina Faso reported 3 cases in two different locations, lifting its number from two different outbreaks to 40 for the year so far. The Central African Republic reported 1 more case from RS5 province, putting its 2020 total so far at 3.

Chad added 2 cases to its total, one each in Tandjile and Logone Oriental provinces, for 79 cases for the year from two different outbreaks. Ivory Coast reported 1 more case, in Poro, raising its number for the year to 52. And finally, South Sudan reported 3 more in different locations, pushing its number for 2020 to 15, all linked to an outbreak in Chad.
Nov 5 GPEI update

COVID-19 Scan for Nov 06, 2020

News brief

Study finds greater severity, disability in COVID-19 strokes

A University College London (UCL) and UCL Hospital study this week found that COVID-19–associated ischemic strokes—caused by an obstruction of blood vessels in the brain—are more severe and more likely to result in disability or death than non-COVID strokes are, and Asian people are especially hard-hit.

Researchers in the Journal of Neurology, Neurosurgery & Psychiatry studied 86 COVID-19–positive stroke patients admitted to 13 hospitals in England and Scotland from Mar 9 to Jul 5, comparing stroke severity and outcomes with 1,384 COVID-19–negative stroke patients admitted during the same period.  

Strokes were more likely to be severe in infected patients (severity score 8 vs 5, P < 0.002), and stroke patients were only half as likely to leave the hospital without disability as those without COVID-19 (median disability score 4 vs 3, P < 0.0001). COVID-19 stroke patients also had significantly higher rates of in-hospital mortality (19.8% inpatient death vs 9.6%, P < 0.0001).

COVID-19–related strokes were twice as likely to be caused by blockage of more than one large blood vessel in the brain (17.9% vs 8.1%, P< 0.03), suggesting abnormal blood clotting. Infected patients had higher levels of D-dimers (P < 0.01)—a protein marker for blood stickiness that may explain greater stroke severity and poorer outcomes.

"Some of the differences relate to what other studies are uncovering about COVID-19, in that it might make blood stickier and more likely to clot," lead researcher Richard Perry, MD, PhD, of UCL and UCL Hospital said in a college press release.

The researchers found that Asian people were overrepresented—nearly 1 in 5—in the COVID-19 stroke group (18.8% vs 6.7%, P < 0.0002). "Our study suggests that COVID-19 has had more impact on strokes in the Asian community than in other ethnic groups," Perry said in the UCL release. "We cannot say from our data whether this is because people of Asian descent are more likely to catch COVID-19, or whether Asian patients with COVID-19 are more likely to have ischaemic strokes, or both."
Nov 3 J Neurol Neurosurg Psychiatry study
Nov 5 UCL news release
Nov 5 BMJ news release

 

Health benefits, socioeconomic differences in telework access

New data from the Centers for Disease Control and Prevention (CDC) and their state partners today show that the ability to telework reduces the risk of contracting SARS-CoV-2, the virus that causes COVID-19. The data highlight socioeconomic differences in access to telework, and the need for increased worker safety measures in industries for which telework options are not available.

The multistate study in today's Morbidity and Mortality Weekly Report (MMWR) examined 314 symptomatic adults who sought COVID-19 testing at outpatient testing or healthcare centers from Jul 1 to Jul 29, of whom 153 (49%) were SARS-CoV-2–positive. Participants reported their telework status for the 2 weeks preceding illness onset, with the percentage who reported teleworking on a full- or part-time basis significantly lower among infected patients (35%) than among control participants (53%).

Participants who reported teleworking were more likely to be non-Hispanic white (P < 0.01), have a college degree or higher (P < 0.01), have health insurance (P < 0.01), earn an income of $75,000 (P < 0.01), and report close contact with a person with a known COVID-19 case (P = 0.03). No significant differences were noted in most community exposures, but COVID-19–positive participants were more likely to report going to an office or school setting in the two weeks prior to illness onset (odds ratio, 1.8; 95% confidence interval, 1.2 to 2.7).

"Providing the option to work from home or telework when possible, is an important consideration for reducing the risk for SARS-CoV-2 infection," the study authors write. "In industries where telework options are not available, worker safety measures should continue to be scaled up to reduce possible worksite exposures."
Nov 6 MMWR study

ASP Scan (Weekly) for Nov 06, 2020

News brief

Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans

UK study finds CRP tests tied to lower antibiotic prescribing for cough

The use of point-of-care C-reactive protein (CRP) tests in primary care practices reduced the odds of prescribing antibiotics for cough by 21%, a non-significant but clinically relevant reduction, researchers reported yesterday in Eurosurveillance.

Using a pragmatic randomized controlled trial design, researchers from Public Health England allocated the top 19 antibiotic prescribing general practices in Northern England to an intervention group that used CRP point-of-care tests (POCTs) for patients who had symptoms of acute cough, and a control group using standard practice. The eight practices allocated to the intervention arm, with a patient population of 47,000, were given a CRP-POCT machine and 100 CRP tests to use over 6 months.

The primary objective of the study was to determine if the intervention practices had reduced odds of prescribing for lower respiratory tract infection, acute cough, bronchitis, and chest infection. The researchers also evaluated patient satisfaction questionnaires.

The eight practices undertook 268 CRP tests over 6 months. A strong majority of CRP results (78%; 209 of 268) indicated no infection, and management of these patients mainly followed National Institute for Health and Care Excellence (NICE) guidance for self-care and no antibiotics (90%; 188/209). But only 12 (22%) of 54 CRP results that indicated a delayed antibiotic should be considered were managed in line with NICE guidance.

Patients reported that CRP testing was comfortable (88%), convenient (84%), useful (92%), and explained well (85%). Patients believed CRP POCT aided clinical diagnosis, provided quick results, and reduced unnecessary antibiotic use. In consultations for which the diagnosis mentioned cough, intervention practices had an estimated 21% reduction (95% confidence interval: 0.46 to 1.35) in the odds of prescribing an antibiotic compared with the controls.

"In routine general practice, CRP POCT use was variable," the authors wrote. "Non-significant reductions in antibiotic prescribing may reflect small sample size due to non-use of tests. While CRP POCT may be useful, primary care staff need clearer CRP guidance and action planning according to NICE guidance."
Nov 5 Eurosurveill study

 

Bacteriophages used in COVID patients with resistant bacterial infections

Originally published by CIDRAP News Nov 3

Eight COVID-19 patients in Texas who have secondary carbapenem-resistant Acinetobacter baumannii (CRAB) infections are receiving investigational bacteriophage therapy from biotechnology company Adaptive Phage Therapeutics (APT), company officials announced yesterday.

In collaboration with the Walter Reed Army Institute of Research, Bacterial Diseases Branch, APT scientists identified two bacteriophages from the company's PhageBank library that were active against bacterial isolates from the hospitalized patients, and they are using those phages to treat the patients under Food and Drug Administration (FDA) emergency Investigational New Drug requests. The company also says it's receiving and analyzing CRAB isolates from new patients daily to identify other potential bacteriophage matches.

The use of bacteriophage therapy in the eight patients came in response to requests in late September from the Rio Grande Valley Collaborative (RGVC), a network of 11 healthcare facilities in south Texas treating COVID-19 patients. RGVC data revealed that mortality rates were more than twice as high in COVID-19 patients with secondary CRAB infections than those without secondary CRAB infections.

"We are pleased to have been able to successfully deploy our investigational PhageBank therapy in response to this outbreak in COVID-19 patients in Texas," Greg Merril, APT's CEO and co-founder, said in a press release. "Our PhageBank deployment represents the first time our technology, originally developed by the Department of Defense, has been used to treat multidrug-resistant secondary bacterial infections in COVID-19 patients."

Merril said the company is working with the FDA to expand early access to PhageBank–based therapies for COVID-19 patients.
Nov 2 APT press release

 

ED study finds high rate of antibiotics for asymptomatic bacteriuria

Originally published by CIDRAP News Nov 3

A study of hospitalized patients admitted through the emergency department (ED) for asymptomatic bacteriuria (ASB) at more than 40 hospitals found that nearly 75% received antibiotics, US researchers reported today in Open Forum Infectious Diseases.

The study, which included 43 hospitals participating in the Michigan Hospital Medicine Safety Consortium, looked at all patients with ASB who were admitted through the ED February 2018 through February 2020. ASB is frequent among hospitalized patients and is commonly treated with antibiotics, even though national guidelines recommend against antibiotic therapy. Because unnecessary antibiotic treatment is common in EDs, the researchers wanted to evaluate how often antibiotic treatment for ASBs is initiated by emergency medicine (EM) clinicians.

The primary outcomes was the percentage of patients who had antibiotic treatment initiated by an EM clinician, and secondary outcomes included length of hospitalization and Clostridioides difficileinfection within 30 days. The researchers also assessed factors associated with antibiotic treatment and length of antibiotic therapy.

Of the 2,461 patients admitted through the ED and ultimately determined to have ASB, 1,830 (74.4%) were treated with antibiotics, with a median treatment duration of 6 days. Urine cultures were ordered by EM clinicians in 1,970 patients (80%), and antibiotic treatment was initiated by an EM clinician in 68.5% of those treated with antibiotics (1,253 of 1,830). When antibiotic treatment was initiated by EM clinicians, 79.2% (993 of 1,253) of patients remained on an antibiotic for 3 or more days.

Predictors of EM clinician treatment of ASB versus no treatment included dementia (odds ratio [OR], 1.43; 95% confidence interval [CI], 1.11 to 1.84), spinal cord injury (OR, 5.92; 95% CI, 1.36 to 25.72), presence of a urinary catheter (OR, 1.54; 95% CI, 1.17 to 2.03), incontinence (OR, 1.81; 95% CI, 1.40 to 2.33), and altered mental status (OR, 2.34; 95% CI, 1.82 to 3.00). Patients treated with antibiotics were more likely to have C difficile infection than those who didn't receive antibiotics (0.9% vs 0%) and have longer hospital stays (5.1 vs 4.2 days).

"These findings identify the ED as a key target to reduce antibiotic use and improve outcomes in hospitalized patients with ASB," the authors wrote.
Nov 3 Open Forum Infect Dis abstract

 

Study highlights role of hospital floors in spread of healthcare pathogens

Originally published by CIDRAP News Nov 2

Hospital room floors could be an underappreciated source of healthcare-associated pathogen spread, including those resistant to antibiotics, according to a study today in Infection Control and Hospital Epidemiology.

In the abstract from the March 2020 Decennial International Conference on Healthcare-Associated Infection, researchers from the Northeast Ohio Veterans Administration (VA) Healthcare System and Cleveland VA Medical Center observed the interactions of patients, hospital workers, and portable equipment in thoroughly cleaned hospital rooms of 17 newly admitted patients who had tested negative for carriage of methicillin-resistant Staphylococcus aureus (MRSA). They then collected cultures from patient skin and room surfaces, including the floors, one to three times a day, focusing on surfaces in contact with personnel and portable equipment.

One or more environmental cultures were found to be MRSA-positive in the rooms of 10 patients (59%), while Clostridioides difficile and vancomycin-resistant Enterococci were each found in the rooms of two patients. Patients interacted with an average of 2.4 hospital workers and 0.6 portable devices per hour of observation. In a subset of patients, MRSA appeared on the hospital room floors within hours of admission, and was subsequently found on patient beds, high-touch surfaces, and patient socks within 24 hours.

Molecular typing conducted in several patient rooms found that the spa type of the MRSA isolates on the floors was the same as isolates recovered from other sites, but the direct transfer of pathogens to personnel or equipment to high-touch surfaces was not detected.

"Hand hygiene is critical, but we need to develop practical approaches to reduce under-appreciated sources of pathogens to protect patients," senior author Curtis Donskey, MD, an epidemiologist at the Cleveland VA Medical Center, said in a press release from the Society for Healthcare Epidemiology of America (SHEA), which sponsors the journal.
Nov 2 Infect Control Hosp Epidemiol abstract
Nov 2 SHEA press release

This week's top reads

Our underwriters